Broken Arrow Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in Broken Arrow
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
Broken Arrow News
Why Silicon Valley’s vision of the future is broken—and how to fix it
Google futurist, argues big tech's imagination has been hijacked by sci-fi and earnings calls. He offers a simple way for any leader to get back to what made Silicon Valley great.
Black lungs and broken promises: The high cost of breathing in Delhi
Modern medicine added decades, but pollution steals years back. Delhi residents lose 8.2 years to toxic air. We dissect this complex regional crisis, the failed efforts, and the shocking factors ...
A Derelict Spaceship Hides a Terrible Secret in This Deep Space Sci-Fi Horror Flick on Tubi
A ship mechanic awakens from cryosleep to a broken ship, cannibalistic creatures and a disaster in deep space.
‘Chaotic’ HHS Overhaul a Wrecking Ball Toward a Better FDA: Former CIO
The upheaval of the Health and Human Services workforce and leadership leaves much to be desired in terms of delivery, recently retired FDA Chief Information Officer Vid Desai tells BioSpace, but the ...